- Home
- QNCX vs GDO Comparison
QNCX vs GDO Comparison
Compare QNCX & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- GDO
- Stock Information
- Founded
- QNCX 2012
- GDO 2009
- Country
- QNCX United States
- GDO United States
- Employees
- QNCX N/A
- GDO N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- GDO Finance Companies
- Sector
- QNCX Health Care
- GDO Finance
- Exchange
- QNCX Nasdaq
- GDO Nasdaq
- Market Cap
- QNCX 47.7M
- GDO 86.3M
- IPO Year
- QNCX 2019
- GDO N/A
- Fundamental
- Price
- QNCX $2.00
- GDO $11.71
- Analyst Decision
- QNCX Strong Buy
- GDO
- Analyst Count
- QNCX 5
- GDO 0
- Target Price
- QNCX $8.00
- GDO N/A
- AVG Volume (30 Days)
- QNCX 376.8K
- GDO 39.4K
- Earning Date
- QNCX 08-12-2025
- GDO 01-01-0001
- Dividend Yield
- QNCX N/A
- GDO 9.81%
- EPS Growth
- QNCX N/A
- GDO N/A
- EPS
- QNCX N/A
- GDO N/A
- Revenue
- QNCX N/A
- GDO N/A
- Revenue This Year
- QNCX N/A
- GDO N/A
- Revenue Next Year
- QNCX N/A
- GDO N/A
- P/E Ratio
- QNCX N/A
- GDO N/A
- Revenue Growth
- QNCX N/A
- GDO N/A
- 52 Week Low
- QNCX $0.51
- GDO $11.21
- 52 Week High
- QNCX $2.45
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- QNCX 70.90
- GDO 62.04
- Support Level
- QNCX $1.55
- GDO $11.70
- Resistance Level
- QNCX $1.71
- GDO $11.83
- Average True Range (ATR)
- QNCX 0.15
- GDO 0.09
- MACD
- QNCX 0.02
- GDO -0.00
- Stochastic Oscillator
- QNCX 89.09
- GDO 63.27
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.